Metropolitan Life Insurance Company (MetLife)’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1	Closed	-$183K	–	2665
2016 Q3	$183K	Hold	1	–	–	﹤0.01%	2391
2016 Q2	$159K	Buy	+1	New	+$118K	﹤0.01%	2488
2016 Q1	–	Sell	-1	Closed	-$151K	–	2552
2015 Q4	$151K	Hold	1	–	–	﹤0.01%	2430
2015 Q3	$159K	Hold	1	–	–	﹤0.01%	2440
2015 Q2	$364K	Buy	+1	New	+$264K	﹤0.01%	1974

Other funds holding NVIV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICM

IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NVIV Position: Q4 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q4 2016, closing a stake of 1 share — an estimated $183K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NVIV in Q2 2015 and held it in 5 quarters. The position peaked at $364K in Q2 2015. 51 funds tracked by Wall St. Rank hold NVIV as of Q4 2016.

Metropolitan Life Insurance Company (MetLife) reported no remaining InVivo Therapeutics Holdings Corp position as of Q4 2016 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1 InVivo Therapeutics Holdings Corp share in Q4 2016, an estimated $183K.
Metropolitan Life Insurance Company (MetLife) first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s InVivo Therapeutics Holdings Corp position peaked at $364K in Q2 2015.
51 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2016, filed 14 Feb 2017.